Serum may resume vaccine export in July/August
Bangladesh entered into a deal with the Serum Institute of India (SII) to purchase 30 million doses of a potential vaccine being developed by AstraZeneca for Covid-19
Bangladesh entered into a deal with the Serum Institute of India (SII) to purchase 30 million doses of a potential vaccine being developed by AstraZeneca for Covid-19